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Summary In a population-based registry of 580 patients with non-Hodgkin's lymphoma (NHL) 54 patients
had a primary gastric lymphoma, 42 an intestinal, 113 a primary extranodal lymphoma localised elsewhere
than in the gastrointestinal tract and 371 a primary nodal NHL. Histological specimens were reviewed by a
panel of pathologists and classified according to the Kiel classification and the International Working
Formulation. The 4-year survival rates for primary gastric, intestinal, other extranodal and nodal NHL ranged
from 50 to 60%; the 4-year recurrence-free survival rates were 50%, 35%, 19% and 19%, respectively. Among
patients with localised intermediate-grade disease survival for those with gastric NHL was better than for
those with intestinal lymphoma. Because it is population-based, our study cohort was not subjected to
exclusion due to age, performance scale, etc. and therefore provides a more realistic picture of the occurrence
and presentation of as well as prognosis for lymphoma in the population.
In the Netherlands an estimated 1000 new cases of non-
Hodgkin's lymphoma (NHL) are diagnosed every year
(SOOZ, 1985), 400 of which are primary extranodal lym-
phomas (Haak et al., 1986) while 100-200 are primary gast-
rointestinal NHLs (Brady & Asbell, 1980; Freeman et al.,
1972; Haber & Mayer, 1988).
Most previous data on primary gastrointestinal lymphoma
were obtained from retrospective studies based on patient
records in a given hospital over a period of many decades
(Brooks & Enterline, 1983; Economopoulos et al., 1985;
Haber & Mayer, 1988; Shiu et al., 1986; Thorling, 1984). A
variety of histological classification systems led to controver-
sial conclusions with regard to the association between his-
tological type and prognosis (Dworkin et al., 1982; Weingrad
et al., 1982). In contrast to these hospital studies we analysed
the clinical and histological presentation as well as the sur-
vival data recorded in a population-based registry. The
advantage of such a registry is that both bias due to hospital
referral policy and selection of patients are avoided. In the
Netherlands, eight comprehensive Cancer Centres (CCC)
cover the entire country geographically. In 1981, the regional
NHL Study Group of CCC West (1.58 million inhabitants)
started a population-based registry, as defined by MacCen-
nan et al. (1978), of all new NHL cases. The primary gastric
and intestinal lymphomas in the registry were investigated
and compared with two other categories: other primary ext-
ranodal lymphomas and nodal lymphomas. The present
paper reports the results of this analysis of the four
categories of lymphoma in the population-based registry with
special attention directed to gastric and intestinal NHLs.
Materials and methods
A population-based registry of all new cases of NHL within
the region of the CCCW was started on 1 June 1981, and is
still ongoing. However, for this study, data entry of new
cases ended on 1 September 1986, while entry of follow-up
data ended on 31 December 1987. All hospitals (15) and
pathological laboratories (9) in the region participated
through the NHL Study Group, which consists of 45
specialists. Collection of data and quality controls were per-
formed by the NHL registrars of the CCCW. Included were
all newly diagnosed patients with NHL except those with
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mycosis fungoides, acute lymphoblastic leukaemia, classical
chronic lymphocytic leukaemia and multiple myeloma and
those first diagnosed post-mortem.
In this study the data were divided into four groups on the
basis of the primary involved site coded according to the
International Classification of Diseases for Oncology (ICD-
0, 1976). A distinction was made between prinmary ex-
tranodal lymphomas and primary nodal NHL; primary ex-
tranodal NHL was further subdivided into primary gastric,
intestinal and other primary extranodal lymphoma (primary
gastrointestinal NHL excluded). The NHL was considered a
primary extranodal lymphoma when at initial clinical
examination the patient's symptoms were caused mainly by
extranodal NHL involvement. When an organ localisation
was diagnosed during staging procedures or later in the
course of the disease, the lymphoma was not subsequently
considered a primary extranodal lymphoma. Patients with
primary gastrointestinal lymphoma were defined according to
Lewin et al. (1978). The initial diagnosis and histological
classification of all cases were made by local pathologists. A
panel of four pathologists reviewed all newly diagnosed cases
weekly. All NHLs were registered, but the tumours were only
classified if material was available for additional
immunological and enzyme-histochemical studies (Haak et
al., 1986). In most other cases, in particular large cell
tumours, the character of the lymphoma was confirmed by
immunostaining for CD45-leukocyte common antigen on
paraffin slides (Warnke et al., 1983). The NHLs were
classified according to the Kiel system (Lennert, 1978) with
some modifications for intermediate lymphocytic lymphoma
and true histiocytic lymphoma (Haak et al., 1986) which
were considered additional entities. Lymphomas were graded
as low, intermediate and high-grade malignancy according to
the International Working Formulation (National Cancer
Institute, 1982). Intermediate lymphocytic lymphoma was
considered as intermediate-grade, true histiocytic lymphoma
as high-grade malignancy.
All NHL patients were staged according to the Ann Arbor
Classification system (Carbone et al., 1971); staging was con-
sidered adequate only when physical examination
(Waldeyer's ring included), surgical and/or endoscopy reports
and additional examinations such as bone marrow biopsy,
X-rays (at least chest X-ray), CT-scan of the abdomen or
lymphangiography and isotope scans of the liver and spleen
were performed. All stage IIE primary gastrointestinal lym-
phomas were further subdivided according to Musshoff
(1977) into stages IIIE and 112E. We considered gastric NHL
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with direct extension into adjacent organs (pancreas, liver) as
stage IVE disease, in accordance with the findings of Wein-
grad et al. (1982).
Although the NHL Study Group reached a general con-
sensus on various treatment modalities at the start of the
registry (Table I), no special protocol for the type of surgery
for patients with primary gastrointestinal lymphoma was fol-
lowed. Usually a partial gastrectomy was performed when
the lymphoma was localised in the stomach. Surgical pro-
cedures for intestinal localisations were total resection of the
involved site when cure was considered possible or partial
resection. Lymphoblastic lymphomas were treated as acute
lymphoblastic leukaemia with an induction, consolidation
and maintenance drug scheme. Response to treatment was
assessed according to standard criteria.
Survival time and recurrence-free survival time were cal-
culated from the date of diagnosis. Death with tumour was
considered the endpoint for survival and recurrence of
disease or death the endpoint for recurrence-free survival.
Comparison of survival curves was performed with the log
rank (Matthews & Farewell, 1985). Comparison of survival
rates at specific time points was done using Greenwood's
equation for the standard error of the survival rate. Con-
tingency tables were analysed with the X2 test.
Results
Out of 640 new cases of NHL registered from 1 June 1981,
to I September 1986, 580 were evaluable; the registration
forms of 60 patients were incomplete, 30 of whom were lost
to follow-up.
Gastric and intestinal vs other extranodal vs nodal NHL
Table II lists some patients' characteristics for the two main
groups: primary extranodal and primary>nodal lymphoma.
The extranodal group is further subdivided into primary
gastric, intestinal and other extranodal NHLs. Among the
580 evaluable patients, 209 had primary extranodal lym-
phoma, 54 of which were primary gastric and 42 primary
intestinal lymphoma. Thirteen of the intestinal NHLs were
localised in the small intestine, 16 in the large bowel and
rectum, three at multiple intestinal sites and 10 in the
mesentery. The mesenterial localisations (10 patients) were
considered to be primary intestinal lymphomas in accordance
with the literature (Dragosics et al., 1985; Haber & Mayer,
1988; Weingrad et al., 1982). Because the numbers of patients
per subsite were too small, we analysed these patients with
intestinal NHL as one group, although it is a very
heterogeneous group.
Sex and age Sex distribution differed between the four
groups (X2 = 12.9; d.f. = 3; P = 0.05). Adjusted for age and
sex for the regional population there was no difference in sex
distribution within a group. Although the median ages for
the four groups were similar, 10 patients of the 42 patients
with primary intestinal NHL were younger than 20 years of
age.
Histology The histological subtypes are summarised in
Table III. Twenty-four per cent of all NHLs were not
classified due to the lack of frozen material, in particular
those diagnosed on the basis of endoscopic biopsy specimens;
histological diagnosis was established on endoscopic biopsy
alone in 21 out of 54 gastric lymphoma and four out of 42
intestinal lymphoma. Among the classified lymphomas, high-
grade malignancy was encountered more often in primary
gastrointestinal lymphomas (n = 22 out of the 68, 32%) - in
particular the intestinal (n = 14 out of the 33, 43%) - than in
the group with other extranodal NHL (15%) or primary
nodal NHL (13%) (X2 = 16.9; d.f. = 4; P = 0.002). Taking
the Kiel classification into consideration the type distribution
of the gastric lymphoma was different compared to the other
groups, with a predominance of diffuse centroblastic lym-
phoma (45%). Half of the mesenterial lymphomas were of
the follicular type; this type was very infrequent in the
stomach.
Stage Stage I disease was found in 30-40% of the cases of
extranodal NHL and only 14% ofthosewith nodal lymphoma.
In parallel, 68% ofthe nodal NHLs were stage IV compared to
20 to 50% of the extranodal lymphomas.
Thethreepatientswithgastriclymphomastage IIIEhad NHL
ofthe cardia and pathological regional lymph nodesjust above
and below the diaphragm near the cardia. Sixteen patients with
gastriclymphomahadstageIVEdisease: 10becauseofapositive
bone marrow biopsy without NHL involvement other than the
stomach and six because of additional solitary extranodal
involvement without lymph node involvement. Eight patients
with intestinal NHL had stage IVE disease as indicated by
multiplegastrointestinal localisations(n = 3), asolitarycervical
lymph node(n = 3) and apositivebonemarrow biopsywithout
lymph node involvement (n = 2).
Adequate staging procedures as defined by the NHL Study
Group were performed in an equal percentage of the cases of
primary gastric, intestinal lymphoma and nodal NHL (74%,
67% and 69%, respectively; TableII)and in 59% ofthecases of
other primary extranodal lymphomas.
Survival and recurrence-free survival The survival and
recurrence-free survival times for patients with gastric and
intestinal lymphoma in relation to other extranodal and nodal
NHL are shown in Figure 1. No important differences in
survival werepresent between thefourgroups. Upto42months
the intestinal group had the poorest survival. The survival rate
at 48 months, however, was similar for the four groups. The
recurrence-free survival resultsweremarkedly influenced bythe
large number of patients who never achieved complete remis-
sion. At 48 months the gastric lymphoma group, in particular,
had a better prognosis compared to patients with other
extranodal or nodal NHL (Greenwood's equation; P <0.05;
Figure 1b). In the next section, our analysis of gastric and
intestinal lymphomas is presented.
Table I Radiotherapeutic and chemotherapeutic protocols for NHL
patients, listed according to stage and grade of malignancy
Workingformulation
Stage Low Intermediate High
I wait and see radiotherapy CHOP
radiotherapy (35-40 Gy)
(35-40 Gy)/
chlorambucil
II} see stage I CHOP CHOP
112-IV CVP CHOP CHOP
CVP: cyclophosphamide 300 mg m-2 orally on days 1-5, vincristine
1.4 mg m-2 (max. 2 mg) i.v. on day 1, prednisone 60 mg orally on days
1 -5. CHOP: cyclophosphamide 750mg m-2 i.v. on day 1, adriamycine
50mg m-2 i.v. on day 1, vincristine 1.4 mg m-2 (max. 2 mg) i.v. on day
1, prednisone 60 mg orally on days 1 -5.
Table II Characteristics of patients with NHL (n = 580)
Primary extranodal NHL Nodal NHL
Characteristics Stomach Intestine Other
Number of patients 54 42 113 371
Sex: M/F 33/21 22/20 39/74 186/185
Age:
Median in years 65 65 66 64
Range 20-87 0-95 4-94 0-91
Stage*
I 21 (15) 12 (7) 35 (17) 51 ( 34)
II 20 (16) 67 ( 53)
III 6 (4) 10 (8)
II2 8 (7) 12 (8)
III 3( 3) 0(0) 1( 1) 82( 52)
IV 16 (11) 8 ( 5) 57 (33) 171 (118)
Total 54 (40) 42 (28) 113 (67) 371 (257)
*The number of patients adequately staged is given in parentheses.PRIMARY GI NHL 747
Table III Histological classification
Primary extranodal NHL Nodal NHL
Primary gastrointestinal NHL Other
Stomach Intestine
Classified 35 (100%) 33 (100%) 73 (100%) 300 (100%) Low grade 2 ( 5%) 9 ( 27%) 20 ( 27%) 93 ( 31%)
Lymphocytic - - - 10
Lymphoplasmocytoid immunocytoma 1 1 11 15
Follicular centroblastic/centrocytic 1 8 9 68
Intermediate grade 24 ( 69%) 9 ( 27%) 39 ( 54%) 161 ( 54%)
Diffuse centroblastic/centrocytic 5 1 6 23
Centrocytic I - 2 4
Intermediate lymphocytic I 1 15
Follicular centroblastic - - 1 13
Diffuse centroblastic 16 4 23 92
Immunocytoma pleomorphic 1 4 6 14
High grade 8 (23%) 14( 43%) 11 (15%) 40( 13%)
Immunoblastic 6 2 8 17
Lymphoblastic - 3 - 13
Burkitt's 1 6 - 2
True histiocytic 1 3 3 8
Others I( 3%) 1( 3%) 3 ( 4%) 6( 2%)
Lennert's lymphoma - - 2 6
T-medium sized lymphoma I I I
Non-classified 19 9 40 71
Total 54 42 113 371
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Figure 1 Survival (a) and recurrence-free survival (b) rates for
patients with primary gastric, intestinal, extranodal lymphoma
other than gastrointestinal lymphoma and nodal NHL (the
number of patients at risk is given in parentheses).
Gastric vs intestinal NHL, prognosticfactors
Treatment The treatment modalities are listed in Table IV.
The majority of the patients with gastric NHL (61%) and
nearly all patients with intestinal lymphoma (90%) under-
went surgery. In our study, patients with primary gastric
NHL stage IE or stage IIE only achieved complete remission
after surgery.
Grade of malignancy (according to the Working Formula-
tion) Too few patients had low-grade gastric lymphoma
(Table III). For this reason wer focussed on intermediate-
grade and high-grade NHL. Although the survival rates for
patients with intermediate-grade gastric NHL and
intermediate-grade intestinal lymphoma did not differ sig-
nificantly within the first 2 years of follow-up (log
rank = 2.41; d.f. = 1; P = 0.12) they did at 4 years (Green-
wood; P <0.05). There was no difference in survival between
high-grade gastric and intestinal lymphoma. (See Figure 2.)
Stage The survival rates for stage IE and IIIE patients with
gastric NHL were similar; however, survival for stage 112E
patients was as poor as that for stage IVE disease. For this
reason, we compared the survival data for patients with
localised lymphoma (stage IE + stage IIIE) with those with
more extensive disease (stages 112E, IIIE and IVE). Localised
gastric lymphoma tended to have a better survival rate than
localised intestinal NHL although the difference was not
significant (log-rank = 1.74; d.f. = 1; P = 0.18). Survival rates
for patients with extensive disease were equal for those with
gastric and intestinal NHL. (See Figure 3.)
Figures 2 and 3 suggest that there might be a difference in
survival between localised intermediate-grade gastric and in-
testinal lymphoma; despite the small numbers of patients
(n = 14 and n = 5), Figure 4 shows a significant difference
(log rank = 4.41; d.f. = 1; P = 0.03).
Discussion
In this study we analysed all primary gastrointestinal lym-
phomas diagnosed in a clearly defined population over a
short period of time. Since most studies are based on a
hospital registry or clinical investigations instead of a popu-
lation-based registry, our patients represent a wider age range
(0-94 years) than is found in the reports of others (Dragosics
et al., 1985; Economopoulos et al., 1985). Moreover, since a
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Table IV Treatment modalities related to the stage of the primary gastrointestinal NHL
Surgery No surgery
IE + IIIE II2E + IIIE + IVE IE + IIIE II2E + IIIE + IVE
Stomach
no additional treatment 8 ( 8) 1 ( 0) - 1 (0)
chemotherapy alone 7 ( 5) 6 ( 4) 2 (0) 15 (1)
radiotherapy alone 6 ( 6) 3 (2) 0 (0)
radiotherapy + chemotherapy I (1) 4 ( 0)
Total 22 (20) 11 ( 4) 5 (2) 16 (1)
Intestine
no additional treatment 5 (1) 4 ( 0)
chemotherapy alone 16 ( 7) 9 ( 4) 3 (1)
radiotherapy alone I ( I)
radiotherapy + chemotherapy 3 ( 3) 1 (0)
Total 22 (9) 16 (7) 4 (1)
The number of patients who achieved complete remission is given in parentheses.
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Figure 2 Survival of patients with primary gastric (n = 54) and
primary intestinal NHL (n = 42) subdivided into those wtih
intermediate-grade and those with high grade malignancy accord-
ing to the Working Formulation (the numnber of patients at risk
is given in parentheses).
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Figure 4 Survival of patients with localised intermediate-grade
NHL of the stomach (n = 14) and the intestine (n = 5).
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Figure 3 Survival of patients with primary gastric (n = 54) _nd
primary intestinal NHL (n = 42) subdivided into those wtih
localised and those with more disseminated disease (the number
of patients at risk is given in parentheses).
population-based registry can be studied after a shorter per-
iod of registration diagnostic procedures and therapeutic ap-
proach are less likely to vary within the study period.
In the majority of series published (Green tt al., 1979;
Haber & Mayer, 1988; Weingrad et al., 1982), p*imary gast-
rointestinal lymphoma exhibits a marked predilection for
males. In our registry and other reports (Brady & Asbell,
1980; Dragosics et al., 1985) both sexes were equally repre-
sented. The incidence of intestinal NHL varies considerably
(Aozasa et al., 1988; Haber & Mayer, 1988; Weingrad et al.,
1982), particularly the relative incidence for the small intes-
tine: from 9% (Dragosics et al., 1985) to 59% (Weingrad et
al., 1982) of all primary gastrointestinal lymphomas. These
differences might be explained by selection of patients: some
studies did not include children (Dragosics et al., 1985; Econ-
omopoulos et al., 1985; Weingrad et al., 1982), whereas
Burkitt's and lymphoblastic lymphomas are relatively more
frequent in young people (Haber & Mayer, 1988).
Grading according to the International Working Formula-
tion appeared to be related to survival in our series (Figures
2 and 4). In other studies only a weak (or no) association
was found between prognosis and histological type as given
by the Rappaport and/or Lukes-Collins classification system
(Dragosics et al., 1985; Dworkin et al., 1982; Haber &
Mayer, 1988; Thorling, 1984). When the different
classification systems were applied to the same histological
CJ)
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material, the Kiel classification system and the International
Working Formulation were found to have the better disc-
riminating capabilities (Dragosics et al., 1985; Dworkin et al.,
1982).
We found a better 1 year survival rate for nodal NHL but
a higher 4-year survival rate for patients with primary gastric
lymphoma (Figure la). Probably, the initially better but later
poorer survival of patients with nodal NHL is caused by the
higher percentage of low-grade malignancies among patients
with nodal NHL compared to those with primary gastric
lymphoma (Table IUI). It is well known that although pa-
tients with low-grade NHL can achieve CR by means of
therapy, relapse and death with tumour can rarely be avoi-
ded (Ciampi et al., 1981).
Our stage distribution for primary gastrointestinal lym-
phoma is in accordance with observations of some authors
'(Blackledge et al., 1979; Haber & Mayer, 1988). Notably
higher percentiges for stage IE and IIE diseasejwill be found
when the definition of primary gastrointestinal lymphoma is
based on the more rigid criteria proposed by Dawson et al.
(1961), who excluded cases with bone marrow localisation
(Dragosics et al., 1985). In our study, 10 out of 16 patients
with stage IV gastric NHL and two out of eight with stage
IV intestinal NHL would have had stage IE disease according
to physical examination and CT-scan of the abdomen but
became stage IV after bone marrow biopsy. Because of the
lack of nodal involvement we believe that these patients
should nevertheless be included in the primary gastrointes-
tinal lymphoma group. Once more these data emphasise the
importance of adequate staging procedures (Come & Chab-
ner, 1979).
Since the Ann Arbor system was not considered suitable
for the staging of gastrointestinal lymphomas, other staging
systems were set up (Blackledge et al., 1979; Crowther &
Rankin, 1983; Musshoff, 1977). In our study the modification
of the Ann Arbor system by Musshoff (1977) proved to be
useful as a prognostic determinant, which is in accordance
with the findings of others (Dawson et al., 1961; Weingrad et
al., 1982). Analysis of the relation between stage and prog-
nosis showed that survival was better for patients with local-
ised (stages I and IIIE) primary gastric lymphoma than for
those with extensive disease. Patients with localised gastric
lymphoma tended to have a better survival than those with
intestinal NHL.
The best treatment for primary gastric lymphoma is a
matter of active debate. Many investigators (Dworkin et al.,
1982; Gospodarowicz et al., 1983; Haber & Mayer, 1988;
Shiu et al., 1986) claim that surgery plus postoperative
radiotherapy gives the best chance of survival for those with
limited disease. However, in these series, irradiation was
consistently given postoperatively, so it is impossible to
estimate its impact on survival. More recently, chemotherapy
alone or in combination with surgery and/or radiotherapy
has been used for limited as well as more extensive disease
(Brooks & Enterline, 1983; Economopoulos et al., 1985; Gos-
podarowicz et al., 1983; Haber & Mayer, 1988; Maor et al.,
1984; Weingrad et al., 1982). In our series chemotherapy
alone did not seem to be successful in achieving CR (11%),
in contrast to the combination surgery plus chemotherapy
with or without radiotherapy (52%). The choice of surgery as
treatment modality was apparently not based on the stage of
disease (Table IV). Complications such as perforation and
gastrointestidal bleeding have been described (List et al.,
1988; Sheridan et al., 1985; Weingrad et al., 1982) after
chemotherapy. None of our patients receiving chemotherapy
developed such complications, nor did those described by
Economopoulos (Economopoulos et al., 1985). The possible
beneficial effect of curative or debulking surgery before
chemotherapy, i.e. to prevent perforation and gastrointestinal
bleeding, has not yet been established.
Unlike noAal lymphomas, many primary gastric and intes-
tinal lymphpmas are presumed to behave clinically as uni-
focal tumours presenting in a localised fashion which might,
therefore, be-curable by local radical treatment (Brooks &
Enterline, 1983; Dragosics et al., 1985; Haber & Mayer,
1988). Howe'ver, the far greater likelihood of systemic rather
than isolated recurrence in patients with gastric and intestinal
NHL (Haber & Mayer, 1988; Figures lb, 3 and 4) raises
reservations ab6ut the lack of dissemination at presentation
and therefore the justification for adjuvant local irradiation.
Optimal mapagement of patients with primary gastric and
intestinal lymphoma can be determined only by multicentre
prospective trials.
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